Categories
Part C Medicare Advantage Part D Prescription Drug

About the Medicare GLP-1 Bridge Program

Beginning July 1, 2026, a new federal initiative called the Medicare GLP-1 Bridge Program will allow individuals enrolled in a Part D plan to access certain highly sought-after weight-loss drugs for a flat copay of $50 a month.

According to the Centers for Medicare & Medicaid Services (CMS), this temporary demonstration program will run through December 31, 2027. The goal is to make these treatments more affordable while the government evaluates long-term coverage models.

Here are the essential details you need to know about who qualifies, what is covered, and how to get started.

1. Who Is Eligible?

You must be enrolled in a standalone Medicare Part D prescription drug plan or a Medicare Advantage plan that includes drug coverage. (This excludes the MA-Only plans that do not include drug coverage.) However, because this is a medical demonstration, you cannot simply request the $50 rate at the pharmacy counter. Your doctor must submit a Prior Authorization showing you meet specific medical categories based on your Body Mass Index (BMI):

  • Tier 1: A BMI of 35 or higher (no other health conditions required).

  • Tier 2: A BMI of 30 to 34.9 plus at least one of these conditions: heart failure, uncontrolled high blood pressure, or chronic kidney disease.

  • Tier 3: A BMI of 27 to 29.9 plus at least one of these conditions: pre-diabetes, a history of a heart attack, a history of a stroke, or peripheral artery disease.

Note: The program specifically excludes patients who have Type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease, as those individuals are typically already eligible for GLP-1 coverage directly through standard Part D plans.

2. Which Medications Are Included?

The $50 monthly price is the result of a negotiated agreement between the federal government and certain drug manufacturers. The program strictly covers specific brand-name formulations prescribed specifically for weight management:

  • Wegovy® (both the standard injectable and the newer oral tablet versions).

  • Zepbound® (strictly limited to the KwikPen® formulation; standard single-dose vials or pens are not covered).

  • Foundayo® (Eli Lilly’s newly approved oral pill).

Medications like Ozempic® and Mounjaro® are not part of this $50 weight-loss program because they are FDA-approved to treat Type 2 diabetes and are already handled under standard Medicare Part D formularies.

3. The “Fine Print” Seniors Need to Know

Because the Bridge program operates entirely outside of the traditional Medicare Part D design, there are a few unique rules to keep in mind:

  • Out-of-Pocket Limits: The $50 monthly copay does not count toward your standard Part D deductible or your annual $2,100 out-of-pocket maximum.

  • Extra Help: Because the program includes a flat $50 copay for everyone who qualifies, the federal Low Income Subsidy (Extra Help) and New York State EPIC cost-sharing protections do not apply to this program.

  • Supply Limits: The program will only cover 28-day or 30-day supplies at a time.

How to Take Action

You do not need to sign up for a new insurance plan to participate. If you think you meet the BMI and health criteria, schedule an appointment with your doctor. Your physician will need to write the prescription with specific instructions for the Bridge program, and they will submit the required medical paperwork directly to the program’s central processor (managed by Humana) to approve your $50 rate. You may want to provide your provider with a copy of the CMS Prescriber Guide and the CMS Pharmacy Operational Framework. for their review.

Click below and watch our June 9 “Ask the Experts” interview where Chris, Kate and I answer some questions about the GLP-1 Bridge Program:


An interesting article comparing several GLP-1 medications: https://www.health.com/glp-1s-weight-loss-8674445

 

Categories
Medicare A & B

Your 2026 Medicare Part B and D Premiums

May Be Increased. Or Eliminated.

The 2026 standard monthly premium for Medicare Part B beneficiaries is $202.90.

However, your 2026 Medicare Parts B and D premiums could be higher or lower – based on your prior or current income.

  • Higher? Yes. If the Modified Adjusted Gross Income (MAGI) on your 2024 tax filing exceeded $109,000 ($218,000 joint) your 2026 Medicare Parts B and D premiums are increased. This will be withheld from your 2026 Social Security benefit. Here is more information about the Income Related Monthly Adjustment Amount (IRMAA) for Parts B and D
  • Lower? Yes. If your current annual income is below 186% of the Federal Poverty Level you will be eligible for the Medicare Savings QI Program, regardless of assets, and will not be paying any Part B premium.

 

  • If you are being charged IRMAA and had a life-changing event that resulted in a reduction in your income, you may be eligible for a reduction in IRMAA. Call Social Security at 1-800-772-1213 for instructions on how to file an appeal via the SSA-44 form.
  • Plan ahead. Assuming the law is not changed, check with your financial planner or tax preparer to confirm whether your 2025 tax filing will trigger a 2027 IRMAA.
  • Or, if your current monthly income is below $2,426 individual / $3,279 couple one of our agents listed below and we can review whether you are eligible for the Medicare Savings QI Program.

 

Questions?

Our licensed, independent and certified agents are available to answer your questions about Parts A, B, IRMAA and other Medicare topics. Send us a note below to request an individual consultation.

Contact Us
First
Last
1
Your State *
Agent Request (in alphabetical order) *
Are You an Existing Client? *
This helps us prepare for our conversation
How Did You Hear About Us? *
Categories
Medicare Part C Medicare Advantage Part D Prescription Drug

Medicare Annual Notice of Change

“The ANOCs are in the mail.”
Each year, by September 30, individuals enrolled in a Medicare Advantage (Part C) or Medicare Part D Prescription Drug plan receive by mail a document called Annual Notice of Change (ANOC.)
The ANOC document spells out upcoming changes to the plan you are currently enrolled in and compares those changes to the current year.
Points to Remember:
Your ANOC document is only for the plan you are enrolled in and not any other plan that may be available to you.
The document will confirm that if you take no action during the Annual Enrollment Period, your plan will be renewed January 1 with the new terms.

If your Medicare Advantage or Part D drug plan is being discontinued in 2026, you will receive by October 2 a Notice of Termination instead of the Annual Notice of Change. That plan termination notice must include a list of other plans offered in your county. Our team of licensed and independent agent advisors represent multiple companies and can assist you with selecting a new plan matching your needs.

October 1: This is the first day when we can discuss with you other 2026 plans available in your area. If you have any questions about your ANOC document, our team of licensed, certified and independent agents are available for a complimentary no-obligation review of the announced changes to your Medicare coverage. Click here to locate, call and or send a note to our agent near you.
October 15: This is the day the 2026 Medicare Annual Enrollment Period begins. During this period, which ends on December 7, 2025, you can enroll in or change your Part C Medicare Advantage or Part D Medicare Prescription Drug plan.

Additionally, this is also an important time to protect yourself from fraud and unsolicited behavior.
You may receive phone calls, emails, or mail from individuals offering assistance with your Medicare coverage. Do not allow anyone to pressure you into sharing personal information over the phone, especially your Medicare number, Social Security number, or banking details.
Telemarketing for Medicare Advantage plans without your prior consent is illegal, and Medicare and Social Security will never contact you by phone.